318 related articles for article (PubMed ID: 30252871)
1. Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation.
Gabbia D; Pozzo L; Zigiotto G; Roverso M; Sacchi D; Dalla Pozza A; Carrara M; Bogialli S; Floreani A; Guido M; De Martin S
PLoS One; 2018; 13(9):e0204336. PubMed ID: 30252871
[TBL] [Abstract][Full Text] [Related]
2. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
[TBL] [Abstract][Full Text] [Related]
3. Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis.
Gabbia D; Pozza AD; Albertoni L; Lazzari R; Zigiotto G; Carrara M; Baldo V; Baldovin T; Floreani A; Martin S
World J Gastroenterol; 2017 Nov; 23(42):7519-7530. PubMed ID: 29204052
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity.
Ahmadi A; Niknahad H; Li H; Mobasheri A; Manthari RK; Azarpira N; Mousavi K; Khalvati B; Zhao Y; Sun J; Zong Y; Ommati MM; Heidari R
Toxicol Lett; 2021 Oct; 349():12-29. PubMed ID: 34089816
[TBL] [Abstract][Full Text] [Related]
5. Semi-quantitative profiling of bile acids in serum and liver reveals the dosage-related effects of dexamethasone on bile acid metabolism in mice.
Wang X; Wang F; Lu Z; Jin X; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1095():65-74. PubMed ID: 30055378
[TBL] [Abstract][Full Text] [Related]
6. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress.
Muchova L; Vanova K; Zelenka J; Lenicek M; Petr T; Vejrazka M; Sticova E; Vreman HJ; Wong RJ; Vitek L
J Cell Mol Med; 2011 May; 15(5):1156-65. PubMed ID: 20518850
[TBL] [Abstract][Full Text] [Related]
7. Promising toxicological biomarkers for the diagnosis of liver injury types: Bile acid metabolic profiles and oxidative stress marker as screening tools in drug development.
Masubuchi N; Nishiya T; Imaoka M; Mizumaki K; Okazaki O
Chem Biol Interact; 2016 Aug; 255():74-82. PubMed ID: 26365562
[TBL] [Abstract][Full Text] [Related]
8. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
[TBL] [Abstract][Full Text] [Related]
9. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
[TBL] [Abstract][Full Text] [Related]
10. β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids
Klag T; Thomas M; Ehmann D; Courth L; Mailänder-Sanchez D; Weiss TS; Dayoub R; Abshagen K; Vollmar B; Thasler WE; Stange EF; Berg CP; Malek NP; Zanger UM; Wehkamp J
Front Immunol; 2018; 9():1735. PubMed ID: 30100908
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats.
Esrefoglu M; Gül M; Emre MH; Polat A; Selimoglu MA
World J Gastroenterol; 2005 Apr; 11(13):1951-6. PubMed ID: 15800985
[TBL] [Abstract][Full Text] [Related]
12. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
13. The effects of chitosan and low dose dexamethasone on extrahepatic cholestasis after bile duct ligation in Wistar rats.
Olteanu D; Filip A; Mureşan A; Nagy A; Tabaran F; Moldovan R; Decea N; Catoi C; Clichici S
Acta Physiol Hung; 2012 Mar; 99(1):61-73. PubMed ID: 22425809
[TBL] [Abstract][Full Text] [Related]
14. Effects of dexamethasone on small bowel and kidney oxidative stress and histological alterations in bile duct-ligated rats.
Ozturk H; Eken H; Ozturk H; Buyukbayram H
Pediatr Surg Int; 2006 Sep; 22(9):709-18. PubMed ID: 16896816
[TBL] [Abstract][Full Text] [Related]
15. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
Wang L; Wu G; Wu F; Jiang N; Lin Y
J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
[TBL] [Abstract][Full Text] [Related]
16. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
Aksu B; Umit H; Kanter M; Guzel A; Aktas C; Civelek S; Uzun H
Acta Histochem; 2010 May; 112(3):259-69. PubMed ID: 19217652
[TBL] [Abstract][Full Text] [Related]
17. D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
Zhao SS; Li NR; Zhao WL; Liu H; Ge MX; Zhang YX; Zhao LY; You XF; He HW; Shao RG
Acta Pharmacol Sin; 2018 Feb; 39(2):213-221. PubMed ID: 28748913
[TBL] [Abstract][Full Text] [Related]
18. Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury
Cao F; Liu P; Zhang X; Hu Y; Dong X; Bao H; Kong L; Wang L; Gong P
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610157
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone restores transforming growth factor-β activated kinase 1 expression and phagocytosis activity of Kupffer cells in cholestatic liver injury.
Hsieh CS; Chuang JH; Chou MH; Kao YH
Int Immunopharmacol; 2018 Mar; 56():310-319. PubMed ID: 29414666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
